Neurogenic Bladder Clinical Trial
Official title:
Urological Deterioration in Secondary Tethered Cord Syndrome and Clue to Detect It
Secondary tethered cord syndrome (STCS) has been diagnosed with signs of progressive deterioration in urological or neuroorthopedic systems following primary tethering surgery. However, there is no convincing urological diagnostic clue for STCS.
Tethered cord syndrome (TCS) refers to various problems involving neurologic, orthopedic, and
urologic systems, seen as a result of chronic traction of the spinal cord in patients with
spinal dysraphism. Evidence for neural injury is often assumed irreversible, so untethering
is justified to maintain neural function and prevent further neural damage. Unfortunately,
some patients experienced an aggravation of symptoms following untethering. The probable
causes are assumed to be the neural injury before or during operation, which was revealed
along with dysplastic neural function, neural compression by increasing syrinx and secondary
tethered cord syndrome (STCS) in which postoperative neural adhesion or syrinx limit motion
of spinal and elicit ischemic changes as the spine grows during puberty. The Secondary
Tethered Cord Syndrome is reported as 19% of cases and causes significant progressive
morbidities in those who affected.
Unfortunately, the detection of STCS is not as simple as it thought. Although magnetic
resonance imaging (MRI) often reveals that the cord seems to get straightened, this does not
necessarily mean that is a significant tethering or cord associated with progressive nerve
damage. The variable course of progression and involvement of multiple systems such as lower
extremity, bladder, bowel, and back would not allow a single specialist to draw conclusions
about the presence of secondary tethered cord syndrome. Moreover, the untethering procedure
of STCS may not always be safe and effective. Given the fact that a significant number of 'no
improvement' or new onset complications following redo-untethering, the surgery could not be
attempted without clear evidence. This explains the reason there is only a limited number of
relevant studies so far.
In this study, it aims to delinate the genuine features of secondary tethered cord syndrome
by selecting and analyzing only cases with symptom improvements. Furthermore, it described
their natural history and time course of urological deterioration and characterized by the
urodynamic changes before and after the redo-untethering.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02978638 -
Electrical Stimulation for Continence After Spinal Cord Injury
|
N/A | |
Enrolling by invitation |
NCT06429631 -
The Effect of CIC Education on QOL and Compliance With Mobile Application in Individuals With Spinal Cord Injury.
|
N/A | |
Completed |
NCT03573726 -
Use of a Diurnal Indwelling Urethral Catheter to Improve Quality of Life
|
N/A | |
Recruiting |
NCT06059066 -
Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction
|
N/A | |
Completed |
NCT01429090 -
Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution
|
Phase 1 | |
Recruiting |
NCT05587101 -
Neurogenic Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis
|
||
Terminated |
NCT03843073 -
Connected Catheter- Safety and Effectiveness Study
|
N/A | |
Terminated |
NCT04059159 -
Connected Catheter - Safety and Effectiveness Study
|
N/A | |
Completed |
NCT05861024 -
Urinary Calculi After Bladder Augmentation in Children
|
||
Completed |
NCT05858840 -
Urinary Artificial Sphincter in Children
|
||
Completed |
NCT04074616 -
Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation
|
N/A | |
Completed |
NCT05683938 -
GentleCathâ„¢ Air Intermittent Catheter Smartwatch Real Life Pilot Study
|
||
Completed |
NCT04543552 -
A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children
|
||
Active, not recruiting |
NCT06247033 -
Efficacies of Different Managements in Patients With Overactive Bladder With Stroke
|
N/A | |
Withdrawn |
NCT01305681 -
Bacterial Properties With LoFric® Catheters During Clean Intermittent Catheterization
|
Phase 1/Phase 2 | |
Recruiting |
NCT04248322 -
Qualitative Assessment of the Impact of TTNS on QOL and Participation
|
||
Recruiting |
NCT05301335 -
Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study
|
N/A | |
Recruiting |
NCT04924569 -
Continence Care Registry
|
||
Completed |
NCT01716624 -
Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder
|
Phase 3 | |
Completed |
NCT01297647 -
Incidence of Urinary Tract Infection After Urodynamic Investigation
|
N/A |